In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

BACKGROUND: Oxacillin continues to be an important agent in the treatment of staphylococcal infections; many generic products are available and the only requirement for their approval is demonstration of pharmaceutical equivalence. We tested the assumption that pharmaceutical equivalence predicts th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Carlos A, Agudelo, Maria, Zuluaga, Andres F, Vesga, Omar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897798/
https://www.ncbi.nlm.nih.gov/pubmed/20525378
http://dx.doi.org/10.1186/1471-2334-10-153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897798/
https://www.ncbi.nlm.nih.gov/pubmed/20525378
http://dx.doi.org/10.1186/1471-2334-10-153

Ejemplares similares